Skip to main content

Table 3 Antiplatelet and anticoagulation medication use by chronic kidney disease status (N = 934)

From: Intracranial haemorrhage detected by cerebral computed tomography after falls in hospital acute medical wards

Medication eGFR ≥30
n (%)
eGFR < 30
n (%)
Anticoagulant
 None 677 (80.8) 71 (74.0)
 Warfarin 53 (6.3) 18 (18.7)
 NOAC 77 (9.2) 3 (3.1)
 Therapeutic enoxaparin 31 (3.7) 4 (4.2)
Antiplatelet
 None 541 (64.6) 50 (52.1)
 Single 250 (29.8) 35 (36.5)
 Dual agent 47 (5.6) 11 (11.5)
  1. NOAC apixaban, rivaroxaban, dabigatran
  2. eGFR estimated glomerular filtration rate in ml/min/1.73m2